Article

Juxtacanalicular connective tissue or basement membrane in Schlemm's canal site of outflow resistance

Aqueous outflow resistance seen in the eyes of patients with glaucoma most likely is generated either in the extracellular matrix of the juxtacanalicular connective tissue or the basement membrane of Schlemm's canal, said Mark Johnson, PhD, of the Department of Biomedical Engineering, Northwestern University, Evanston, IL.

Aqueous outflow resistance seen in the eyes of patients with glaucoma most likely is generated either in theextracellular matrix of the juxtacanalicular connective tissue or the basement membrane of Schlemm's canal, saidMark Johnson, PhD, of the Department of Biomedical Engineering, Northwestern University, Evanston, IL.

Over and above this process, the location of giant vacuoles and pores seen in the cells of the endothelium inSchlemm's canal are likely responsible for modulating this outflow resistance, which is inversely proportionalto the number of pores. The mechanical stresses that are generated when the aqueous moves through theendothelium are likely responsible for the formation of the giant vacuoles and pores, Dr. Johnson explained.

An issue that needs further study is in vitro perfusion of the inner wall endothelium. This factor, according toDr. Johnson, may provide insight into the process by which vacuoles and pores form in this unique endotheliumand why inner wall pore density appears to be reduced greatly in patients with glaucoma.

Dr. Johnson and his colleagues proposed that funneling-movement of the aqueous into the nearestpore-causes the fluid to go through only a small part of the juxtacanalicular connective tissue orbasement membrane.

"This hypodynamic interaction greatly increases the flow resistance of the system," he said. "The flowresistance of the juxtacanalicular connective tissue plus the pores is much greater than the flow resistance ofeither of the two alone."

Other research issues that need to be addressed are creation of a cell culture model of the inner wall systemthat can study basal to apical perfusion, the basal lamina, and attachment to the juxtacanalicular connectivetissue; the biophysics of pore formation; determination of the permeability of juxtacanalicular connectivetissue and the basal lamina; determination of which extracellular micromolecules are responsible for generatingthe bulk of outflow resistance; and measurement of the pressure decrease across the inner wall in glaucomatouseyes, Dr. Johnson said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.